HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 5 of 49

6 Table 2. Recessive forms (type 2) of LGMDs associated with CM, listed according to the subtype nomenclature used in this guide New classification system in parentheses Subtype (prior name) Gene Protein Cellular localization LGMD2D (LGMD R3) SGCA α-Sarcoglycan Sarcolemma LGMD2E (LGMD R4) SGCB β-Sarcoglycan Sarcolemma LGMD2C (LGMD R5) SGCG γ-Sarcoglycan Sarcolemma LGMD2F (LGMD R6) SGCD δ-Sarcoglycan Sarcolemma LGMD2G (LGMD R7) TCAP Telethonin Sarcomere LGMD2I (LGMD R9) FKRP Fukutin-related protein Golgi apparatus LGMD2J (LGMD R10) TTN Titin Sarcomere LGMD2N (LGMD R14) POMT2 Protein O-mannosyltransferase 2 Endoplasmic reticulum LGMD2Q (LGMD R17) PLEC Plectin Intermediate filament Duchenne, Becker, and Recessive Limb-girdle Muscular Dystrophies

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders